Literature DB >> 18630215

Chikungunya fever, falciparum malaria, dengue fever, Japanese encephalitis... are we listening to the warning signs for public health in India?

Anurag Bhargava1, Biswaroop Chatterjee.   

Abstract

The 2005-epidemic of Chikungunya fever highlights the weaknesses of public health in India. The failure to control mosquitoes, and the illnesses transmitted by them, has resulted in recurrent outbreaks all over the country. This is inevitable given the larger scenario: neglect of the basic requirements of health; poor political support for health; a weak public health capacity; centralised programmes for control based on selective interventions, and poorly-planned development projects which have created conditions ideal for the outbreak of disease. All these issues are concerns for public health ethics and must be addressed to tackle the problems posed by mosquito-borne as well as other communicable diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18630215     DOI: 10.20529/IJME.2007.007

Source DB:  PubMed          Journal:  Indian J Med Ethics        ISSN: 0974-8466


  4 in total

1.  Assessment of changes of vector borne diseases with wetland characteristics using multivariate analysis.

Authors:  A M Sheela; S Sarun; J Justus; P Vineetha; R V Sheeja
Journal:  Environ Geochem Health       Date:  2014-11-21       Impact factor: 4.609

2.  Development of a vaccine to prevent Japanese encephalitis: a brief review.

Authors:  Viroj Wiwanitkit
Journal:  Int J Gen Med       Date:  2009-12-29

3.  Outdoor spatial spraying against dengue: A false sense of security among inhabitants of Hermosillo, Mexico.

Authors:  Pablo A Reyes-Castro; Lucía Castro-Luque; Rolando Díaz-Caravantes; Kathleen R Walker; Mary H Hayden; Kacey C Ernst
Journal:  PLoS Negl Trop Dis       Date:  2017-05-17

4.  The Organization, Implementation, and Functioning of Dengue Surveillance in India-A Systematic Scoping Review.

Authors:  Eva Pilot; Vasileios Nittas; Gudlavalleti Venkata S Murthy
Journal:  Int J Environ Res Public Health       Date:  2019-02-24       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.